Production (Stage)
Dynavax Technologies Corporation
DVAX
$10.27
-$0.13-1.25%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -8.58% | -10.45% | |||
| Total Other Revenue | 227.37% | -23.81% | |||
| Total Revenue | -5.37% | -10.66% | |||
| Cost of Revenue | 3.79% | 16.96% | |||
| Gross Profit | -12.43% | -24.43% | |||
| SG&A Expenses | 42.21% | -3.45% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 25.34% | 4.56% | |||
| Operating Income | -3,828.92% | -95.33% | |||
| Income Before Tax | -1,382.93% | -61.50% | |||
| Income Tax Expenses | -406.74% | -73.97% | |||
| Earnings from Continuing Operations | -1,463.11% | -59.93% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -1,463.11% | -59.93% | |||
| EBIT | -3,828.92% | -95.33% | |||
| EBITDA | -1,250.80% | -86.95% | |||
| EPS Basic | -1,496.73% | -58.94% | |||
| Normalized Basic EPS | -311.80% | -60.53% | |||
| EPS Diluted | -1,878.29% | -64.48% | |||
| Normalized Diluted EPS | -353.21% | -61.00% | |||
| Average Basic Shares Outstanding | -2.41% | -2.43% | |||
| Average Diluted Shares Outstanding | -18.40% | -1.15% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||